Stonnington Group, LLC Jazz Pharmaceuticals PLC Transaction History
Stonnington Group, LLC
- $381 Million
- Q1 2023
A detailed history of Stonnington Group, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Stonnington Group, LLC holds 2,500 shares of JAZZ stock, worth $266,825. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,500
-0.0%
Holding current value
$266,825
Previous $398,000
8.29%
% of portfolio
0.1%
Previous 0.11%
Shares
5 transactions
Others Institutions Holding JAZZ
# of Institutions
514Shares Held
57.1MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$755 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$688 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$263 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$254 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$160 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.69B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...